drug-dev.com

Webside score drug-dev.com

Drug Development & Delivery - The Latest Methods in Drug Development

 Genereret Marts 15 2026 09:34 AM

Gammel data? OPDATER !

Scoren er 64/100

SEO Indhold

Titel

Drug Development & Delivery - The Latest Methods in Drug Development

Længde : 68

Perfekt, din titel indeholder mellem 10 og 70 bogstaver.

Beskrivelse

Drug Development & Delivery is a print and online publisher that presents the latest scientific methods in drug development for professionals.

Længde : 142

Perfekt, din meta beskrivelse indeholder mellem 70 og 160 karakterer.

Nøgleord

Dårligt! Vi kan ikke finde nogle meta nøgleord på din side! Brug denne gratis online meta generator for at oprette nye nøgleord.

Og Meta Egenskaber

Godt, din side benytter Og egenskaberne

Egenskab Indhold
locale en_US
type website
title Drug Development & Delivery - The latest scientific methods in drug development
description Drug Development & Delivery is a print and online content provider that presents the latest scientific methods in drug development for professionals in R&D, APIs, pre-formulation, formulation development and analytical methods.
url https://drug-dev.com/
site_name Drug Development and Delivery
image https://drug-dev.com/wp-content/uploads/2018/06/Drug-Dev-Homepage.jpg
image:width 2048
image:height 1062
image:type image/jpeg

Overskrifter

H1 H2 H3 H4 H5 H6
1 4 52 6 1 0
  • [H1] Don’t miss out on this exclusive content!
  • [H2] EXPERT CONTENT & RESOURCES
  • [H2] EXCLUSIVE WHITEPAPERS
  • [H2] EXCLUSIVE WEBINARS
  • [H2] MARKET NEWS & TRENDS
  • [H3] SPECIAL FEATURE - Artificial Intelligence in Drug Discovery, Development & Delivery
  • [H3] FORMULATION FORUM - Solid Oral Dosages: Controlled Release of Drugs
  • [H3] LEADERSHIP PANEL - Trends to Watch for in 2026
  • [H3] PREFILLABLE SYRINGE SYSTEM - Beyond Components: Designing Prefillable Syringe Systems to Streamline Success
  • [H3] CONTROLLED RELEASE - Challenges in Consistent & Predictable Delivery of Drugs Using Oral Controlled Release Technologies
  • [H3] EXECUTIVE INTERVIEW - Incannex Healthcare: Pioneering the Future of Cannabinoid & Psychedelic Therapies
  • [H3] CELL & GENE THERAPY - What the Industry Can Learn From Baby KJ About Optimizing CRISPR Development
  • [H3] PLATFORM TECHNOLOGY - How PolyPid’s PLEX Unlocks the Potential of Local & Prolonged Release
  • [H3] MAB FORMULATION & FILL-FINISH - Obstacles in Monoclonal Antibody Formulation & Fill-Finish
  • [H3] EXECUTIVE INTERVIEW - CERo Therapeutics: A Novel Approach to Treating Cancer
  • [H3] MRNA THERAPEUTICS - Strategies for Enhanced Stability, Targeted Delivery & Safe Translation
  • [H3] 2026 COMPANY PROFILES & CAPABILITIES
  • [H3] PURIFICATION STRATEGIES - Purification at Scale: Overcoming Chromatography Challenges for Advanced Modalities
  • [H3] DRUG DEVELOPMENT - Common CMC Pitfalls in Orphan Drug Development
  • [H3] 3D PRINTING - The Future of 3D Printing in Pharma: Aprecia’s Vision for Transformative Medicine
  • [H3] Biocatalysis Without Barriers for Efficient Small Molecule Process Development
  • [H3] VIDEO - Built for the Clinic: Smart Drug Product Design for Accelerated Clinical Development
  • [H3] Atossa Therapeutics: Unlocking the Platform Potential of (Z)-Endoxifen Across Oncology & Rare Disease
  • [H3] Drug Combination Screening in Oncology: Advancing Predictive Strategies for Precision Drug Development
  • [H3] How Can a Stage-Based Program to Determine HME Applicability Benefit Your API?
  • [H3] WHITE PAPER - Stop Guessing. Start Predicting: Rethinking Early Oral Drug Development
  • [H3] WHITE PAPER - Small Molecules: Choosing the Right Development Path
  • [H3] WHITE PAPER - How Advanced Containment Technology Is Reshaping High-Potency API Micronization
  • [H3] WHITE PAPER - Advancements in Intradermal Delivery: From Historic Techniques to Modern Innovations
  • [H3] WHITE PAPER - An Insoluble Problem? Overcoming Oral Drug Solubility Challenges With Functional Polymers
  • [H3] ON-DEMAND WEBINAR: Drug Product Design for Delivery of Challenging Molecules
  • [H3] WEBINAR - Vytal: The RTU Snap-Fit System for Container Closure Solutions – Setting the Standard for the Future
  • [H3] WEBINAR ON DEMAND: Precision at Scale: Enabling Novel Therapeutics With Nanoparticle Manufacturing
  • [H3] WEBINAR: Introducing Key Concepts in Tableting Research: Unleashing Essential Concepts and Strategies for Enhanced Formulation Development
  • [H3] WEBINAR ON DEMAND: Advantages of Carbopol® Polymers in Oral Formulations
  • [H3] Vetter Des Plaines Facility is the German American Chamber of Commerce’s Investment of the Year
  • [H3] Neuland to Open Commercial Peptide Facility as part of Planned Phased Expansion
  • [H3] Lonza & Genetix Biotherapeutics Extend Commercial Manufacturing Agreement for ZYNTEGLO
  • [H3] Centauri Therapeutics Granted FDA QIDP Status for CTX-187 Treatment of Gram-Negative Bacterial Infections
  • [H3] Upperton Submits MHRA License Application for Annex 1 Sterile Manufacturing Facility Following APS Validation
  • [H3] Biologos Appoints New CEO, Celebrates 50 Years of Growth & Innovation
  • [H3] Medicus Pharma Reports Positive Phase 2 Topline Data Observing 73% Clinical Clearance & 40% Histological Clearance
  • [H3] LabVantage Solutions Introduces LabVantage CORTEX, Advancing its LIMS Platform for AI-Driven Laboratory Operations
  • [H3] Codexis Signs Agreement to Manufacture 50 g siRNA Using its ECO Synthesis Manufacturing Platform
  • [H3] FUJIFILM Biotechnologies Unveils ShunzymeX Precision Purification Technology
  • [H3] BioDuro & Cenra Launch Joint Venture to Expand Resilient Global API Manufacturing Capacity
  • [H3] NorthSea Therapeutics Announces Achievement of Key Regulatory Milestones for Orziloben
  • [H3] ESTEVE CDMO Commences $15.5 Million Expansion of Chicago Small Molecule API Facility
  • [H3] Bioxytran Reports Positive Study Results for a Broad-Range Antiviral Drug in Mild-to-Moderate COVID-19
  • [H3] Quotient Sciences Extends Commercial Manufacturing Partnership for Ultra-Rare Disease Treatment
  • [H3] Neurizon Initiates Dosing of NUZ-001 in HEALEY ALS Platform Trial
  • [H3] MGS Acquires European-Based Medical Injection Molder Knudsen Plast A/S
  • [H3] TARA-002 Demonstrates 68% Complete Response Rate at 6 Months in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
  • [H3] etherna´s Intratumoral mRNA/LNP Platform Advances to Clinical Testing in Nonmelanoma Skin Cancer Led by Almirall
  • [H3] SolasCure Completes Phase 2 Clinical Trial Demonstrating Accelerated Healing With Aurase Wound Gel
  • [H3] MARKET SEGMENTS
  • [H3] CORPORATE
  • [H4] VIDEO SPOTLIGHT
  • [H4] COMPANY PROFILES
  • [H4] TECHNOLOGY & SERVICES SHOWCASE
  • [H4] eBOOKS
  • [H4] AUDIO SPOTLIGHT
  • [H4] INDUSTRY EVENTS
  • [H5] Sign Up for a free Subscription

Billeder

Vi fandt 46 billeder på denne side.

43 alt tags mangler eller er tomme. Tilføj alternativ tekst til dine billeder for at gøre siden mere brugervenlig, og for at optimere din SEO i forhold til søgemaskinerne.

Text/HTML balance

Balance : 31%

Optimalt! Denne sides text til HTML fordeling er mellem 25 og 70 procent.

Flash

Perfekt, ingen Flash objekter er blevet fundet på siden.

iFrame

Beklager! Din side har iFrames og det kan medføre i yderst dårlig læsning af søgerobotterne.

URL Omskrivning

Godt. Dine links ser venlige ud!

Underscores i links

Perfekt! Ingen underscores blev fundet i dine links

On-page links

Vi fandt et total af 156 links inkluderende 0 link(s) til filer

Anker Type Juice
upgrade your browser Ekstern Sender Juice
SUBMISSION GUIDELINES Intern Sender Juice
ABOUT US Intern Sender Juice
BACK ISSUES Intern Sender Juice
MEDIA PLANNER Intern Sender Juice
CONTACT Intern Sender Juice
FREE PRINT SUBSCRIPTION Intern Sender Juice
Login Intern Sender Juice
Select a Section Intern Sender Juice
Analytical Testing Intern Sender Juice
Bioavailability & Solubility Intern Sender Juice
Bio Platforms Intern Sender Juice
Drug Delivery Intern Sender Juice
Injection Devices Intern Sender Juice
Excipients Intern Sender Juice
Formulation Development Intern Sender Juice
Contract Services Intern Sender Juice
SPECIAL FEATURE - Artificial Intelligence in Drug Discovery, Development & Delivery Intern Sender Juice
Featured Articles, Intern Sender Juice
FORMULATION FORUM - Solid Oral Dosages: Controlled Release of Drugs Intern Sender Juice
LEADERSHIP PANEL - Trends to Watch for in 2026 Intern Sender Juice
PREFILLABLE SYRINGE SYSTEM - Beyond Components: Designing Prefillable Syringe Systems to Streamline Success Intern Sender Juice
CONTROLLED RELEASE - Challenges in Consistent & Predictable Delivery of Drugs Using Oral Controlled Release Technologies Intern Sender Juice
EXECUTIVE INTERVIEW - Incannex Healthcare: Pioneering the Future of Cannabinoid & Psychedelic Therapies Intern Sender Juice
Executive Interviews, Intern Sender Juice
CELL & GENE THERAPY - What the Industry Can Learn From Baby KJ About Optimizing CRISPR Development Intern Sender Juice
PLATFORM TECHNOLOGY - How PolyPid’s PLEX Unlocks the Potential of Local & Prolonged Release Intern Sender Juice
MAB FORMULATION & FILL-FINISH - Obstacles in Monoclonal Antibody Formulation & Fill-Finish Intern Sender Juice
EXECUTIVE INTERVIEW - CERo Therapeutics: A Novel Approach to Treating Cancer Intern Sender Juice
MRNA THERAPEUTICS - Strategies for Enhanced Stability, Targeted Delivery & Safe Translation Intern Sender Juice
2026 COMPANY PROFILES & CAPABILITIES Intern Sender Juice
PURIFICATION STRATEGIES - Purification at Scale: Overcoming Chromatography Challenges for Advanced Modalities Intern Sender Juice
DRUG DEVELOPMENT - Common CMC Pitfalls in Orphan Drug Development Intern Sender Juice
3D PRINTING - The Future of 3D Printing in Pharma: Aprecia’s Vision for Transformative Medicine Intern Sender Juice
Click here to see all Intern Sender Juice
Biocatalysis Without Barriers for Efficient Small Molecule Process Development Intern Sender Juice
VIDEO - Built for the Clinic: Smart Drug Product Design for Accelerated Clinical Development Intern Sender Juice
Atossa Therapeutics: Unlocking the Platform Potential of (Z)-Endoxifen Across Oncology & Rare Disease Intern Sender Juice
Drug Combination Screening in Oncology: Advancing Predictive Strategies for Precision Drug Development Intern Sender Juice
How Can a Stage-Based Program to Determine HME Applicability Benefit Your API? Intern Sender Juice
Click here to see all Intern Sender Juice
Contact us Intern Sender Juice
WHITE PAPER - Stop Guessing. Start Predicting: Rethinking Early Oral Drug Development Intern Sender Juice
WHITE PAPER - Small Molecules: Choosing the Right Development Path Intern Sender Juice
WHITE PAPER - How Advanced Containment Technology Is Reshaping High-Potency API Micronization Intern Sender Juice
WHITE PAPER - Advancements in Intradermal Delivery: From Historic Techniques to Modern Innovations Intern Sender Juice
WHITE PAPER - An Insoluble Problem? Overcoming Oral Drug Solubility Challenges With Functional Polymers Intern Sender Juice
Click here to see all Intern Sender Juice
ON-DEMAND WEBINAR: Drug Product Design for Delivery of Challenging Molecules Intern Sender Juice
WEBINAR - Vytal: The RTU Snap-Fit System for Container Closure Solutions – Setting the Standard for the Future Intern Sender Juice
WEBINAR ON DEMAND: Precision at Scale: Enabling Novel Therapeutics With Nanoparticle Manufacturing Intern Sender Juice
WEBINAR: Introducing Key Concepts in Tableting Research: Unleashing Essential Concepts and Strategies for Enhanced Formulation Development Intern Sender Juice
WEBINAR ON DEMAND: Advantages of Carbopol® Polymers in Oral Formulations Intern Sender Juice
Click here to see all Intern Sender Juice
Vetter Des Plaines Facility is the German American Chamber of Commerce’s Investment of the Year Intern Sender Juice
Neuland to Open Commercial Peptide Facility as part of Planned Phased Expansion Intern Sender Juice
Lonza & Genetix Biotherapeutics Extend Commercial Manufacturing Agreement for ZYNTEGLO Intern Sender Juice
Centauri Therapeutics Granted FDA QIDP Status for CTX-187 Treatment of Gram-Negative Bacterial Infections Intern Sender Juice
Upperton Submits MHRA License Application for Annex 1 Sterile Manufacturing Facility Following APS Validation Intern Sender Juice
Biologos Appoints New CEO, Celebrates 50 Years of Growth & Innovation Intern Sender Juice
Medicus Pharma Reports Positive Phase 2 Topline Data Observing 73% Clinical Clearance & 40% Histological Clearance Intern Sender Juice
LabVantage Solutions Introduces LabVantage CORTEX, Advancing its LIMS Platform for AI-Driven Laboratory Operations Intern Sender Juice
Codexis Signs Agreement to Manufacture 50 g siRNA Using its ECO Synthesis Manufacturing Platform Intern Sender Juice
FUJIFILM Biotechnologies Unveils ShunzymeX Precision Purification Technology Intern Sender Juice
BioDuro & Cenra Launch Joint Venture to Expand Resilient Global API Manufacturing Capacity Intern Sender Juice
NorthSea Therapeutics Announces Achievement of Key Regulatory Milestones for Orziloben Intern Sender Juice
ESTEVE CDMO Commences $15.5 Million Expansion of Chicago Small Molecule API Facility Intern Sender Juice
Bioxytran Reports Positive Study Results for a Broad-Range Antiviral Drug in Mild-to-Moderate COVID-19 Intern Sender Juice
Quotient Sciences Extends Commercial Manufacturing Partnership for Ultra-Rare Disease Treatment Intern Sender Juice
Neurizon Initiates Dosing of NUZ-001 in HEALEY ALS Platform Trial Intern Sender Juice
MGS Acquires European-Based Medical Injection Molder Knudsen Plast A/S Intern Sender Juice
TARA-002 Demonstrates 68% Complete Response Rate at 6 Months in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Intern Sender Juice
etherna´s Intratumoral mRNA/LNP Platform Advances to Clinical Testing in Nonmelanoma Skin Cancer Led by Almirall Intern Sender Juice
SolasCure Completes Phase 2 Clinical Trial Demonstrating Accelerated Healing With Aurase Wound Gel Intern Sender Juice
Click here to see all Intern Sender Juice
AbbVie Contract Manufacturing Intern Sender Juice
ABITEC Corporation Intern Sender Juice
Abzena Intern Sender Juice
Adare Pharma Solutions Intern Sender Juice
Agno Pharmaceuticals Intern Sender Juice
Almac Group Intern Sender Juice
Aptar Pharma Intern Sender Juice
ARL Bio Pharma Intern Sender Juice
Ascendia Pharmaceutical Solutions Intern Sender Juice
BASF Pharma Solutions Intern Sender Juice
BD Medical - Pharmaceutical Systems Intern Sender Juice
Bespak Intern Sender Juice
BIOVECTRA Intern Sender Juice
Bora Pharmaceuticals Intern Sender Juice
Captisol, brought to you by Ligand Intern Sender Juice
Celanese Intern Sender Juice
Credence MedSystems Inc. Intern Sender Juice
Croda Pharma Intern Sender Juice
Datwyler Intern Sender Juice
DDL Intern Sender Juice
Dyhydromatics Intern Sender Juice
Evonik Health Care Intern Sender Juice
Gattefossé Intern Sender Juice
Genizer Intern Sender Juice
H&T Presspart Intern Sender Juice
Halo Pharma Intern Sender Juice
HCmed Intern Sender Juice
HERMES PHARMA GmbH Intern Sender Juice
Kenox Pharmaceuticals, Inc. Intern Sender Juice
Kindeva Intern Sender Juice
LATITUDE Pharmaceuticals Inc. Intern Sender Juice
Lifecore Biomedical Intern Sender Juice
Lonza Intern Sender Juice
Lyophilization Technology, Inc. Intern Sender Juice
Mikart, LLC Intern Sender Juice
Mitsubishi Gas Chemical Company, Inc. Intern Sender Juice
Nanjing Well Pharmaceutical Group Co., Ltd. Intern Sender Juice
Nipro PharmaPackaging Intern Sender Juice
Oakwood Chemical, Inc. Intern Sender Juice
Pace® Life Sciences Intern Sender Juice
PCI Pharma Services Intern Sender Juice
PharmaCircle Intern Sender Juice
ProMed Pharma, LLC Intern Sender Juice
Proveris Scientific Intern Sender Juice
Quotient Sciences Intern Sender Juice
Resilience US, LLC Intern Sender Juice
Serán Bioscience Intern Sender Juice
Sharp Intern Sender Juice
Stevanato Group Intern Sender Juice
Terumo Pharma Solutions Intern Sender Juice
Thermo Fisher Scientific Intern Sender Juice
UPM Pharmeceuticals Intern Sender Juice
Upperton Pharma Solutions  Intern Sender Juice
Vetter Pharma International GmbH Intern Sender Juice
West Pharmaceutical Services Intern Sender Juice
Woodstock Sterile Solutions Intern Sender Juice
Click to see the latest technologies and services offered by the leading drug delivery companies. Intern Sender Juice
Navigating the Fill Finish Process e-book Intern Sender Juice
Analytical Testing e-book 2025 Intern Sender Juice
Respiratory e-Book 2025 Intern Sender Juice
Analytical Testing e-book 2024 Intern Sender Juice
Respiratory e-Book 2024 Intern Sender Juice
Analytical Testing e-Book 2023 Intern Sender Juice
Respiratory e-Book 2023 Intern Sender Juice
Oral Dosage Drug Delivery Market e-Book 2023 Intern Sender Juice
Aseptic Manufacturing e-Book 2023 Intern Sender Juice
Lyophilization Trends e-Book 2023 Intern Sender Juice
Analytical Testing e-Book 2022 Intern Sender Juice
Respiratory e-Book 2022 Intern Sender Juice
Analytical Testing e-Book 2021 Intern Sender Juice
Respiratory e-Book 2021 Intern Sender Juice
Analytical Testing e-Book 2020 Intern Sender Juice
Respiratory e-Book 2020 Intern Sender Juice
Analytical Testing e-Book 2019 Intern Sender Juice
Respiratory e-Book 2019 Intern Sender Juice
Learn More > Intern Sender Juice
Learn More > Intern Sender Juice
Learn More > Intern Sender Juice
PODD (Partnership Opportunities in Drug Delivery) Ekstern Sender Juice
Privacy Policy Intern Sender Juice
WalkerTek Ekstern Sender Juice

SEO Nøgleord

Nøgleords cloud

clinical formulation drug recently development announced delivery pharma solubility manufacturing

Nøgleords balance

Nøgleord Indhold Titel Nøgleord Beskrivelse Overskrifter
drug 38
development 28
delivery 20
pharma 16
recently 15

Brugervenlighed

Link

Domæne : drug-dev.com

Længde : 12

FavIkon

Godt, din side har et FavIcon!

Printervenlighed

Vi kunne ikke finde en printer venlig CSS skabelon.

Sprog

Godt, dit tildelte sprog er en.

Dublin Core

Denne side benytter IKKE Dublin Core principperne.

Dokument

Dokumenttype

HTML 5

Kryptering

Perfekt. Dit Charset er tildelt UTF-8.

W3C Validering

Fejl : 0

Advarsler : 0

Email Privatliv

Godt! Ingen email adresser er blevet fundet i rå tekst!

Udgået HTML

Godt! Vi har ikke fundet udgåede HTML tags i din kildekode

Hastigheds Tips

Alle tiders! Din webside bruger ikke nestede tabeller.
Advarsel! Din webside benytter inline CSS kode!
Dårligt, din webside har for mange CSS filer (mere end 4).
Dårligt, din webside har for mange JavaScript filer (mere end 6).
Perfekt, din hjemmeside udnytter gzip.

Mobil

Mobil Optimering

Apple Ikon
Meta Viewport Tag
Flash indhold

Optimering

XML Sitemap

Stor, din hjemmeside har en XML sitemap.

https://drug-dev.com/sitemap_index.xml

Robots.txt

https://drug-dev.com/robots.txt

Stor, din hjemmeside har en robots.txt-fil.

Analytics

Stor, din hjemmeside har et analyseværktøj.

   Google Analytics

PageSpeed Insights

Apparat
Kategorier

Free SEO Testing Tool

Free SEO Testing Tool er et gratis SEO redskab der hjælper med din hjemmeside